Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Bioorg Med Chem. 2011 Aug 30;19(21):6447–6453. doi: 10.1016/j.bmc.2011.08.056

Table 1.

T. maritima KDPG aldolase mutants selected for enhanced catalysis of KHO cleavage.

Name Mutations Relative
Expression Level
TM 1 G34R/V172A/R190I ++++
TM 2 K9T/G83E +++
TM 3 *Deletion of first two AA, L16P/V31A/S82C/G83V/F99L/W167R ++
TM 4 V136M ++
TM 5 A30V ++
TM 6 I52F/V135M/T185A +
TM 7 P109S +
TM 8 N150I +
++++

100%;

+++

50%;

++

10%;

+

5% expression relative to wild-type TMA in TMEDA-pUC plasmid

These proteins were selected in a pUC plasmid where the expression of wild-type TMA is 10% of the expression in the TMEDA-pUC plasmid.

These proteins were selected in a pUC plasmid where the expression of wild-type TMA is ~2% of the expression in the TMEDA-pUC plasmid.

*

Signifies a frameshift mutation where expression of the gene is initiated at the third amino acid.